COMPANY PROFILE / #3391
Anto Biosciences
San Francisco, CAAccelerator/Incubator Backed
OVERVIEW
Developer of a multimodal foundation model designed to make the gut microbiome computable and improve understanding of drug response. The company offers a platform that models microbial communities and predicts drug toxicity and efficacy across diverse populations, enabling pharmaceutical researchers to design and optimize molecules for broader effectiveness and reduced failure rates.
已融资0.60
最新估值30.00
员工数2
成立年份2025
公司概况
- Companies
- Anto Biosciences
- Description
- Developer of a multimodal foundation model designed to make the gut microbiome computable and improve understanding of drug response. The company offers a platform that models microbial communities and predicts drug toxicity and efficacy across diverse populations, enabling pharmaceutical researchers to design and optimize molecules for broader effectiveness and reduced failure rates.
- Website
- www.anto.bio
- HQ Location
- San Francisco, CA
- Year Founded
- 2025
- Keywords
- artificial intelligence, bioengineering platform technology, bioinformatics and computational biology, biotechnology, biotechnology and pharmaceuticals, precision medicine
- Competitors
- Microbiotica, BioCorteX, Vedanta Biosciences, Viome Life Sciences, Ginkgo Bioworks
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Accelerator/Incubator Backed
融资与估值
- Total Raised
- 0.60
- First Financing Date
- 01-Sep-2025
- First Financing Size
- 0.50
- First Financing Valuation
- 30.00
- Last Financing Date
- 19-Jan-2026
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 0.10
- Last Financing Valuation
- 30.00
- Last Financing Status
- Completed
- Last Known Valuation
- 30.00
- Last Known Valuation Date
- 19-Jan-2026
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 47.21
- Valuation Estimate Growth Rate
- 57.38%
- Active Investors
- Cameron Urban, gumi, Jake Klamka, LabCentral, Lukasz Jakubowski, Massive Tech Ventures, Montgomery Anderson, PageOne Lab, Ritual Capital, RRE Ventures, Rui Zhang, Sandy Kory, Sara Bellomo, Standard Partners, Wittgenstein Ventures, Y Combinator
- # Active Investors
- 16
- Acquirers
- —
团队与联系人
- Employees
- 2
- Employee Growth %
- 0.00%
- Employee History
- 2026: 2, 2025: 2
- Primary Contact
- Arvid Gollwitzer
- Primary Contact Title
- Co-Founder & Chief Executive Officer
- Primary Contact Email
- arvid@anto.bio
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 2.08x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 70
- Majestic Referring Domains
- 54
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #3391 · 所有字段均按数据库原值展示。